Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Burger

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 7, 2020
Cumulative pemetrexed dose increases the risk of nephrotoxicityN de Rouw, R J Boosman, H van de Bruinhorst, et al.
British Journal of Clinical Pharmacology|November 26, 2004
Effect of efavirenz treatment on the pharmacokinetics of nelfinavir boosted by ritonavir in healthy volunteersC J L la Porte, M J A de Graaff-Teulen, E P H Colbers, et al.
Therapeutic Drug Monitoring|August 15, 2000
Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavirP W Hugen, D M Burger, M de Graaff, et al.
Tropical Medicine & International Health : TM & IH|December 17, 2017
Peg-interferon and ribavirin treatment in HIV/HCV co-infected patients in Thailand: efficacy, safety and pharmacokineticsE J Smolders, N Thammajaruk, C T M M de Kanter, et al.
British Journal of Clinical Pharmacology|March 26, 2018
A pharmacological rationale for improved everolimus dosing in oncology and transplant patientsR Ter Heine, N P van Erp, H J Guchelaar, et al.
Antiviral Therapy|June 22, 2001
Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trialN A Foudraine, S Jurriaans, G J Weverling, et al.
Cancer Chemotherapy and Pharmacology|October 4, 2024
A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexedN de Rouw, R Beunders, O Hartmann, et al.
HIV Medicine|March 28, 2008
Steady-state nevirapine plasma concentrations are influenced by pregnancyJ F J B Nellen, M Damming, M H Godfried, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected childrenD M Burger, A M van Rossum, P W Hugen, et al.
Clinical Pharmacology and Therapeutics|December 23, 2011
Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1P Kasirye, L Kendall, K K Adkison, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Lung Cancer (Amsterdam, Netherlands)|June 7, 2020
Cumulative pemetrexed dose increases the risk of nephrotoxicityN de Rouw, R J Boosman, H van de Bruinhorst, et al.
British Journal of Clinical Pharmacology|November 26, 2004
Effect of efavirenz treatment on the pharmacokinetics of nelfinavir boosted by ritonavir in healthy volunteersC J L la Porte, M J A de Graaff-Teulen, E P H Colbers, et al.
Therapeutic Drug Monitoring|August 15, 2000
Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavirP W Hugen, D M Burger, M de Graaff, et al.
Tropical Medicine & International Health : TM & IH|December 17, 2017
Peg-interferon and ribavirin treatment in HIV/HCV co-infected patients in Thailand: efficacy, safety and pharmacokineticsE J Smolders, N Thammajaruk, C T M M de Kanter, et al.
British Journal of Clinical Pharmacology|March 26, 2018
A pharmacological rationale for improved everolimus dosing in oncology and transplant patientsR Ter Heine, N P van Erp, H J Guchelaar, et al.
Antiviral Therapy|June 22, 2001
Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trialN A Foudraine, S Jurriaans, G J Weverling, et al.
Cancer Chemotherapy and Pharmacology|October 4, 2024
A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexedN de Rouw, R Beunders, O Hartmann, et al.
HIV Medicine|March 28, 2008
Steady-state nevirapine plasma concentrations are influenced by pregnancyJ F J B Nellen, M Damming, M H Godfried, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected childrenD M Burger, A M van Rossum, P W Hugen, et al.
Clinical Pharmacology and Therapeutics|December 23, 2011
Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1P Kasirye, L Kendall, K K Adkison, et al.
Pageof 14